Click to view our statement on Accessibility

Suggested Searches

    Popular Searches

    Back
    Foley Viewpoints

    Patenting Risk Evaluation & Mitigation Strategies; For Pharmaceuticals: A New Life Cycle Management Target for Patents?

    02 January 2009

    Author(s)

    Stephen B. Maebius

    Washington, D.C. 202.672.5569

    David L. Rosen

    Washington, D.C. 202.672.5430

    Judith A. Waltz

    San Francisco 415.438.6412

    Related Insights

    View All Posts
    21 May 2025 Tariff & International Trade Resource

    What Every Multinational Company Should Know About … Customs Enforcement and False Claims Act Risks (Part III)

    We complete the series on “Customs Enforcement and False Claims Act Risks” with Part III, which focuses on preparing for the most common FCA risks arising from improper management of import operations.
    02 June 2025 Events

    Biotech Panel Discussion & Happy Hour

    Join Foley & Lardner LLP along with Biotech XYZ for an engaging evening event featuring a dynamic panel discussion and a lively happy hour.
    03 June 2025 Events

    Biotech Breakfast + Office Hours

    Join Foley & Lardner LLP along with Biotech XYZ for Phase Capitals’ flagship networking biotech breakfast and office hours with Q&A sessions.